Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency - Related Studies

Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency

This study has been completed.

Study NCT00095732. Last updated on June 23, 2005. Information provided by Altus Pharmaceuticals

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Cystic Fibrosis
		Pancreatic Insufficiency

2	Additional conditions recognized in this trial
		Exocrine Pancreatic Insufficiency
		Fibrosis

3	More general conditions related to this trial
		Digestive System Diseases
		Genetic Diseases, Inborn
		Infant, Newborn, Diseases
		Lung Diseases
		Pancreatic Diseases
		Pathologic Processes
		Respiratory Tract Diseases

4	Interventions listed in this trial
		TheraCLEC™ – Total

5	Sponsors listed in this trial
		Altus Pharmaceuticals
		Cystic Fibrosis Foundation